RDY Launches Generic Semaglutide Injection in Canada, First G7 Approval
Dr. Reddy's Laboratories Limited American Depositary Shares · Now $13.63
-0.2% in 7d after detection
Post-detection moves
1h
—
1d
-0.1%
3d
+0.1%
7d
-0.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS